Abstract
Watson for Drug Discovery (WDD) is a cloud-based, end-to-end scalable platform that helps life science researchers discover new disease pathways, new drug targets, and additional drug indications. It ingests both structured and unstructured content from multiple internal and external heterogeneous sources. It then uses natural language processing and domain-specific ontologies to annotate this content so that the machine can read and understand the content more like the way a domain expert would.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bakkar N et al. Artificial intelligence in neurodegenerative disease research: Use of Ibm Watson to identify additional rna-binding proteins altered in amyotrophic lateral sclerosis. Acta neuropathol. 2018;135.2:227–47.
Johnston TH et al. Repurposing drugs to treat L-Dopa-induced dyskinesia in Parkinson’s disease. Neuropharmacology (2018).
Spangler S et al. Automated hypothesis generation based on mining scientific literature. In: Proceedings of the 20th ACM SIGKDD international conference on knowledge discovery and data mining. ACM; 2014.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Spangler, S. (2019). Accelerating Discovery with Cognitive—An Example Cognitive Application for Discovery: Watson for Drug Discovery. In: Betz, U. (eds) Curious2018. Springer, Cham. https://doi.org/10.1007/978-3-030-16061-6_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-16061-6_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16060-9
Online ISBN: 978-3-030-16061-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)